Sernova Receives Authorization to Enroll Second Patient Cohort of Phase 1/2 Trial with Cell Pouch System™ for Type 1 Diabetes – GlobeNewswire
November 03, 2022 07:30 ET | Source: Sernova Corp. Sernova Corp. London, Ontario, CANADA LONDON, Ontario, Nov. 03, 2022 (GLOBE NEWSWIRE) — Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company…